Authors:
GREEN DM
BRESLOW NE
BECKWITH JB
FINKLESTEIN JZ
GRUNDY PE
THOMAS PRM
KIM T
SHOCHAT SJ
HAASE GM
RITCHEY ML
KELALIS PP
DANGIO GJ
Citation: Dm. Green et al., COMPARISON BETWEEN SINGLE-DOSE AND DIVIDED-DOSE ADMINISTRATION OF DACTINOMYCIN AND DOXORUBICIN FOR PATIENTS WITH WILMS-TUMOR - A REPORT FROM THE NATIONAL WILMS-TUMOR STUDY-GROUP, Journal of clinical oncology, 16(1), 1998, pp. 237-245
Authors:
ADAMSON PC
REAMAN G
FINKLESTEIN JZ
FEUSNER J
BERG SL
BLANEY SM
OBRIEN M
MURPHY RF
BALIS FM
Citation: Pc. Adamson et al., PHASE-I TRIAL AND PHARMACOKINETIC STUDY OF ALL-TRANS-RETINOIC ACID ADMINISTERED ON AN INTERMITTENT SCHEDULE IN COMBINATION WITH INTERFERON-ALPHA-2A IN PEDIATRIC-PATIENTS WITH REFRACTORY CANCER, Journal of clinical oncology, 15(11), 1997, pp. 3330-3337
Authors:
SANDERS J
GLADER B
CAIRO M
FINKLESTEIN JZ
FORMAN E
GREEN D
LUBAN N
BLEYER WA
LAMPKIN BC
MURPHY SB
WOODS WG
Citation: J. Sanders et al., GUIDELINES FOR THE PEDIATRIC CANCER CENTER AND ROLE OF SUCH CENTERS IN DIAGNOSIS AND TREATMENT, Pediatrics, 99(1), 1997, pp. 139-141
Citation: Ke. Richkind et al., T(4-19)(Q35-Q13.1) - A RECURRENT CHANGE IN PRIMITIVE MESENCHYMAL TUMORS, Cancer genetics and cytogenetics, 87(1), 1996, pp. 71-74
Authors:
GREEN DM
BECKWITH JB
BRESLOW NE
FARIA P
MOKSNESS J
FINKLESTEIN JZ
GRUNDY P
THOMAS PRM
KIM T
SHOCHAT S
HAASE G
RITCHEY M
KELALIS P
DANGIO GJ
Citation: Dm. Green et al., TREATMENT OF CHILDREN WITH STAGE-II TO STAGE-IV ANAPLASTIC WILMS-TUMOR - A REPORT FROM THE NATIONAL-WILMS-TUMOR-STUDY-GROUP, Journal of clinical oncology, 12(10), 1994, pp. 2126-2131
Authors:
GREEN DM
BRESLOW NE
BECKWITH JB
MOKSNESS J
FINKLESTEIN JZ
DANGIO GJ
Citation: Dm. Green et al., TREATMENT OF CHILDREN WITH CLEAR-CELL SARCOMA OF THE KIDNEY - A REPORT FROM THE NATIONAL WILMS-TUMOR STUDY-GROUP, Journal of clinical oncology, 12(10), 1994, pp. 2132-2137
Authors:
GREEN DM
BRESLOW NE
EVANS I
MOKSNESS J
FINKLESTEIN JZ
EVANS AE
DANGIO GJ
Citation: Dm. Green et al., THE EFFECT OF CHEMOTHERAPY DOSE INTENSITY ON THE HEMATOLOGICAL TOXICITY OF THE TREATMENT FOR WILMS-TUMOR - A REPORT FROM THE NATIONAL-WILMS-TUMOR-STUDY, The American journal of pediatric hematology/oncology, 16(3), 1994, pp. 207-212
Authors:
FINKLESTEIN JZ
MILLER DR
FEUSNER J
STRAM DO
BAUM E
SHINA DC
JOHNSON DG
GYEPES MT
HAMMOND GD
Citation: Jz. Finklestein et al., TREATMENT OF OVERT ISOLATED TESTICULAR RELAPSE IN CHILDREN ON THERAPYFOR ACUTE LYMPHOBLASTIC-LEUKEMIA - A REPORT FROM THE CHILDRENS CANCERGROUP, Cancer, 73(1), 1994, pp. 219-223
Authors:
GAYNON PS
STEINHERZ PG
BLEYER WA
ABLIN AR
ALBO VC
FINKLESTEIN JZ
GROSSMAN NJ
NOVAK LJ
PYESMANY AF
REAMAN GH
CHAPPELL RJ
SATHER HN
HAMMOND GD
Citation: Ps. Gaynon et al., IMPROVED THERAPY FOR CHILDREN WITH ACUTE LYMPHOBLASTIC-LEUKEMIA AND UNFAVORABLE PRESENTING FEATURES - A FOLLOW-UP REPORT OF THE CHILDRENS CANCER GROUP-STUDY CCG-106, Journal of clinical oncology, 11(11), 1993, pp. 2234-2242
Authors:
FINKLESTEIN JZ
NORKOOL P
GREEN DM
BRESLOW N
DANGIO GJ
Citation: Jz. Finklestein et al., DIASTOLIC HYPERTENSION IN WILMS-TUMOR SURVIVORS - A LATE EFFECT OF TREATMENT - A REPORT FROM THE NATIONAL-WILMS-TUMOR-STUDY-GROUP, American journal of clinical oncology, 16(3), 1993, pp. 201-205